Drug · DIN 01908294
NOROXIN
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since June 18, 2005; first marketed December 31, 1990.
- Drug Identification Number (DIN)
- 01908294
- Company (DIN owner)
- Merck Canada IncKirkland, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Solution
- Route
- Ophthalmic
- Therapeutic class (ATC)
- Norfloxacin S01AX12
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| NORFLOXACIN | 3 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- June 17, 2005: NOC 7097New Drug Submission (NDS) · Manufacturer name change
Other DINs named NOROXIN
- DIN 00643025 · Cancelled Post Market